DK3455222T3 - Midler til nuklear billeddannelse og radioterapi målrettet carboanhydrase IX og anvendelser deraf - Google Patents
Midler til nuklear billeddannelse og radioterapi målrettet carboanhydrase IX og anvendelser deraf Download PDFInfo
- Publication number
- DK3455222T3 DK3455222T3 DK17796928.4T DK17796928T DK3455222T3 DK 3455222 T3 DK3455222 T3 DK 3455222T3 DK 17796928 T DK17796928 T DK 17796928T DK 3455222 T3 DK3455222 T3 DK 3455222T3
- Authority
- DK
- Denmark
- Prior art keywords
- carbonic anhydrase
- nuclear imaging
- agents targeting
- radiotherapy agents
- targeting carbonic
- Prior art date
Links
- 108700012439 CA9 Proteins 0.000 title 1
- 102100024423 Carbonic anhydrase 9 Human genes 0.000 title 1
- 238000012633 nuclear imaging Methods 0.000 title 1
- 238000001959 radiotherapy Methods 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/08—Copper compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/06—Aluminium compounds
- C07F5/069—Aluminium compounds without C-aluminium linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662336043P | 2016-05-13 | 2016-05-13 | |
| PCT/US2017/032384 WO2017197251A1 (en) | 2016-05-13 | 2017-05-12 | Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase ix and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3455222T3 true DK3455222T3 (da) | 2022-05-23 |
Family
ID=60266891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17796928.4T DK3455222T3 (da) | 2016-05-13 | 2017-05-12 | Midler til nuklear billeddannelse og radioterapi målrettet carboanhydrase IX og anvendelser deraf |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20190192699A1 (da) |
| EP (1) | EP3455222B1 (da) |
| JP (1) | JP7030061B2 (da) |
| KR (1) | KR102531494B1 (da) |
| CN (1) | CN109476655B (da) |
| AU (1) | AU2017263630B2 (da) |
| CA (1) | CA3024097A1 (da) |
| DK (1) | DK3455222T3 (da) |
| ES (1) | ES2912947T3 (da) |
| LT (1) | LT3455222T (da) |
| PL (1) | PL3455222T3 (da) |
| WO (1) | WO2017197251A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7334147B2 (ja) * | 2017-08-22 | 2023-08-28 | パーデュー・リサーチ・ファウンデイション | 炭酸脱水酵素陽性がんを標的とするｆｂｓａ系治療および放射性造影複合体 |
| WO2020045638A1 (ja) * | 2018-08-30 | 2020-03-05 | 日本メジフィジックス株式会社 | 放射性イミダゾチアジアゾール誘導体化合物 |
| WO2023153847A1 (ko) * | 2022-02-11 | 2023-08-17 | (주)씨바이오멕스 | 탄산탈수소효소 ix를 표적으로 하는 펩타이드 리간드, 이를 포함하는 펩타이드 구조체 및 이들의 용도 |
| WO2023155454A1 (zh) * | 2022-02-15 | 2023-08-24 | 无锡诺宇医药科技有限公司 | 碳酸酐酶ix靶向放射性诊疗药物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2129666A2 (en) * | 2007-04-05 | 2009-12-09 | Siemens Medical Solutions USA, Inc. | Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry |
| RU2498798C2 (ru) * | 2008-01-09 | 2013-11-20 | Моликьюлар Инсайт Фармасьютикалз, Инк. | Ингибиторы карбоангидразы iх |
| CA2835286C (en) * | 2011-05-09 | 2021-03-23 | Visen Medical, Inc. | Carbonic anhydrase targeting agents and methods of using same |
| AU2015212733B2 (en) * | 2014-02-03 | 2018-06-07 | Eidgenoessische Technische Hochschule Zurich | Small molecule drug conjugates |
| US10857246B2 (en) * | 2015-06-01 | 2020-12-08 | The Johns Hopkins University | Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase IX and uses thereof |
-
2017
- 2017-05-12 JP JP2018558351A patent/JP7030061B2/ja active Active
- 2017-05-12 EP EP17796928.4A patent/EP3455222B1/en active Active
- 2017-05-12 LT LTEPPCT/US2017/032384T patent/LT3455222T/lt unknown
- 2017-05-12 PL PL17796928T patent/PL3455222T3/pl unknown
- 2017-05-12 CN CN201780043433.7A patent/CN109476655B/zh active Active
- 2017-05-12 US US16/301,338 patent/US20190192699A1/en not_active Abandoned
- 2017-05-12 AU AU2017263630A patent/AU2017263630B2/en active Active
- 2017-05-12 DK DK17796928.4T patent/DK3455222T3/da active
- 2017-05-12 KR KR1020187035954A patent/KR102531494B1/ko active IP Right Grant
- 2017-05-12 CA CA3024097A patent/CA3024097A1/en active Pending
- 2017-05-12 WO PCT/US2017/032384 patent/WO2017197251A1/en unknown
- 2017-05-12 ES ES17796928T patent/ES2912947T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN109476655B (zh) | 2022-03-08 |
| AU2017263630A1 (en) | 2018-11-22 |
| KR102531494B1 (ko) | 2023-05-10 |
| KR20180136567A (ko) | 2018-12-24 |
| CN109476655A (zh) | 2019-03-15 |
| AU2017263630B2 (en) | 2021-11-04 |
| WO2017197251A1 (en) | 2017-11-16 |
| PL3455222T3 (pl) | 2022-07-11 |
| LT3455222T (lt) | 2022-06-27 |
| CA3024097A1 (en) | 2017-11-16 |
| EP3455222A1 (en) | 2019-03-20 |
| JP7030061B2 (ja) | 2022-03-04 |
| JP2019514984A (ja) | 2019-06-06 |
| EP3455222B1 (en) | 2022-03-02 |
| AU2017263630A8 (en) | 2019-01-17 |
| US20190192699A1 (en) | 2019-06-27 |
| EP3455222A4 (en) | 2019-12-18 |
| ES2912947T3 (es) | 2022-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3283106T3 (da) | Terapeutiske antistoffer og anvendelser deraf | |
| DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
| DK3373883T3 (da) | Medicinsk teknologistation og anvendelsesfremgangsmåde | |
| DK3372034T3 (da) | Fremgangsmåder og indretning til planlægning i uplink | |
| DK3322804T3 (da) | Nuklease-uafhængigt målrettet genredigeringsplatform og anvendelser deraf | |
| DK3302431T3 (da) | Taxanpartikler og anvendelse deraf | |
| DK3294770T3 (da) | Terapeutiske og diagnostiske fremgangsmåder til cancer | |
| DK3380101T3 (da) | Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil | |
| DK3250237T3 (da) | Hemiasterlinderivater til konjugering og terapi | |
| DK2949365T3 (da) | Gåtræningsapparat og gåtræningsfremgangsmåde deraf | |
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| DK3325488T3 (da) | Chiral diaryl-makrocyklus og anvendelse deraf til behandling af cancer | |
| DK3551209T3 (da) | Insulin-fc-fusioner og fremgangsmåder til anvendelse | |
| DK3668512T3 (da) | Pyruvatkinasemodulatorer og anvendelse deraf | |
| DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
| DK3356558T3 (da) | Sirs patogenbiomarkører og anvendelser deraf | |
| DK3256598T3 (da) | Svampestammer og anvendelsesfremgangsmåder | |
| DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
| DK3227483T3 (da) | Elastisk stof og fremgangsmåde til fremstilling | |
| DK3384079T3 (da) | Fibrøs konstruktion og fremgangsmåder i forbindelse hermed | |
| DK3253800T3 (da) | Prostata antigen standarder og bruge deraf | |
| DK3455222T3 (da) | Midler til nuklear billeddannelse og radioterapi målrettet carboanhydrase IX og anvendelser deraf | |
| DK3447078T3 (da) | Kemisk dyvel og anvendelse deraf | |
| DK3448419T3 (da) | Interferon-beta-antistoffer og anvendelser deraf | |
| DK3265126T3 (da) | Kombinationsformulering af tesofensin og metoprolol |